相关实验视频

Updated: Jul 17, 2026

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle

Published on: February 1, 2017

通过HBx突变调节的RPL13AP25调节了对恩特卡维尔和HCC进展的亚最佳病毒学反应

Yang-Hsiang Lin^1,2, Ming-Wei Lai^1,3, Yu-De Chu¹

¹Liver Research Center, Chang Gung Memorial Hospital, Linkou. No. 15, Wenhua 1st Rd., Guishan Dist., Taoyuan City, 333, Taiwan.

Cancer cell international

|June 21, 2025

概括

对慢性乙型肝炎治疗的低于最佳反应可能会导致由于HBx突变导致肝细胞癌 (HCC). 这些突变体对RPL13AP25的升级促进了HCC的进展.

科学领域:

肝病学肝病学是一种肝病学.
病毒学病毒学
在瘤学瘤学.

背景情况:

对于慢性乙型肝炎 (CHB) 存在有效的抗病毒药物,但在一些患者中发生了低于最佳的反应.
长非编码RNAs (lncRNAs) 在调解低于最佳的CHB反应中的作用尚未完全理解.

研究的目的:

研究lncRNAs在CHB患者的亚最佳反应中的贡献.
探索亚最佳反应,HBx突变和肝细胞癌 (HCC) 发展之间的联系.

主要方法:

考克斯回归模型分析了与次优反应相关的临床因素.
乙型肝炎病毒X (HBx) 基因测序在接受恩特卡维尔治疗的患者中进行,这些患者患有HCC.
使用了功能性测试 (Transwell,MTT,异种移植) 和RNA-seq.

主要成果:

低于最佳的反应独立预测HCC的发展.
在5/6名HCC患者中发现了HBx突变,患者的反应不足最佳.
HBx-H94Y/K130M突变增加了ccccDNA积累和细胞迁移,上调RPL13AP25,这是一种与生存率差和HCC进展相关的标志物.

结论:

在亚最佳反应期间选择的HBx-H94Y/K130M突变,通过RPL13AP25上调促进ccccDNA积累.
这种机制有助于肝细胞癌在CHB患者的进展.

更多相关视频

Identifying Inhibitors of the HBx-DDB1 Interaction Using a Split Luciferase Assay System

Identifying Inhibitors of the HBx-DDB1 Interaction Using a Split Luciferase Assay System

Published on: December 21, 2019

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

相关概念视频

Hepatitis

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...